News
GSK PLC GSK shares slid 1.10% to £13.95 Wednesday, on what proved to be an all-around poor trading session for the stock ...
HYDERABAD: Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of ...
By Maggie Fick and Jennifer Rigby LONDON (Reuters) -Drugmakers Bharat Biotech and GSK will cut the price of their malaria ...
Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...
Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...
In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...
Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...
1d
Zacks.com on MSNEMA Accepts GSK's Filing for Linerixibat in Rare Disease-Related ItchGSK's marketing application for linerixibat, targeting cholestatic pruritus in PBC patients, gains EMA acceptance based on phase III success.
Bharat Biotech and GSK to reduce RTS,S malaria vaccine price to under $5 per dose by 2028, enhancing access for children in ...
GSK PLC GSK shares slid 2.06% to £14.50 Wednesday, on what proved to be an all-around positive trading session for the stock ...
As part of a multi-year collaboration, GSK and India’s Bharat Biotech are redoubling their efforts to bring the world’s first malaria vaccine to more countries in need at affordable prices. | The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results